Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial - Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trial.
Front Med (Lausanne)
; 9: 967964, 2022.
Article
in En
| MEDLINE
| ID: mdl-36035422
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
Aspects:
Ethics
/
Patient_preference
Language:
En
Journal:
Front Med (Lausanne)
Year:
2022
Document type:
Article
Affiliation country:
Germany